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The Tenth International Congress of Dermatology
By J. MARTIN BEARE, M D., M.R.C.P.
THIS Congress was held in London in July, 1952, under the presidency of Sir
Achibald Gray. It was the third Congress since 1912, and the only other
occasion when London had the honour of entertaining the world's dermatologists
was in 1896. Forty-five coun;tries, including the U.S.S.R., were represented, and
the attendance was well over one thousand.
The three main topics for discussion were: "The Pathogenesis of Eczema,"
"A.C.T.H. and Cortisone," and "The Treatment of Tuberculosis of the Skin."
Dr. Pillsbury (U.S.A.) indicated the magnitude of the problem of eczema by
stating that the majority of World War II troops suffering from skin disease
in the tropics were suffering from some form of eczema, and more troops were
invalided from the Pacific war theatre because of skin disease than because of
war wounds. The prevalence of eczema in civil life is comparable. Professor
Miescher (Zurich) expressed doubt as to how far we were justified in regarding
eczema as an allergic disease. Dr. Brain (London) discussed the problem of
infantile eczema, and stressed the value of sedatives and careful nursing care.
Some dermatologists were showing increasing doubt about the part played by
food sensitisation in'the production of infantile eczema.
The discussion on A.C.T.H. and Cortisone was opened by Dr. Brunsting
(U.S.A.), who stressed the fact that these drugs do not eradicate the cause of
disease nor do they repair damaged tissue. Rather they act as buffers to
reactions of tissue to injury. With prolonged dosage, undesirable side-effects
include disturbances of electrolyte metabolism, alterations in the psyche, and
signs of hyperadrenalism. There is ever present the liability to develop severe
pyogenic infection, which may often be difficult to detect while the patient is
having the drug. Dr. Ereaux (Canada) discussed the use of cortisone in the
management of pemphigus vulgaris and its variants. He thought that
this disease is the only dermatological condition which consistently merits the
employment of the drug. He had maintained patients up to two and a half years
on cortisone. Dr. Ereaux doubted the wisdom of using cortisone in the treat.
ment of psoriasis, erythrodermias, sarcoidosis and eczematous dermatitis. In
the latter condition great care and experience are required to prevent the develop-
ment of severe erythrodermia when cortisone medication is discontinued. He
concluded that in dermatology A.C.T.H. and cortisone can shorten the course
of a self-limited condition, control many of the serious illnesses and cure but few
of the dermatoses. Dr. Sulzberger (U.S.A.) thought that the effects of the drugs
might be designated as "morbidistatic" - in analogy to "bacteriostatic,"
"fungistatic," etc. He noted that fixed drug eruptions and chronic urticarias
respond poorly or not at all. Local application of cortisone to the skin is not
effective. He was impressed by the value of these drugs as instruments of derma-
tological research, but stressed that these powerful weapons can do great harm
185as well as good. Dr. Prunty (London) noted improvement in renal function in
the early- stages of malignant lupus erythematous. On the other hand, healing of
necrotic areas in cases of lupus erythematous was prevented by the drugs. One
came away from these discussions with the feeling that, even if A.C.T.H. and
cortisone were freely available at a reasonable cost in this country, their value
in practical therapy is extremely limited, and without intimate hospital
supervision their use is never justified.
The symposium on the treatment of tuberculosis of the skin contained papers
by Drs. Charpy (France) and Dowling (Great Britain), who independently
discovered the value of calciferol in the treatment of skin tuberculosis. Calciferol
is still the most valuable agent for these conditions, but emphasis was placed by
a number *of speakers on the value of combining calciferol therapy with other
drugs - especially streptomycin and PAS, and other precedures - especially
curettage and cautery. Dr. Wetherley-Mein (London) believed that calciferol
acts by having an effect on the patient's tissues rather than by any inhibitory
effect on the growth of tubercle bacilli.
Among the two hundred other papers read at the Congress one might pick
out three of more than ordinary interest. The work of Drs. Fitzpatrick and Lerner
(U.S.A.) on melanogenesis, using labelled tyrosine, would appear to offer in the
near future a possible biochemical test for the differentiation of benign and
malignant melanomata; the use of psoralens (plant extracts) in the treatment of
leucoderma offers a hope that this disfiguring condition will soon be manageable;
and Dr. Anderson (London) has been able to demonstrate the great importance
of changes in pH of diseased skin, and the part which these changes must play
in the chronicity of eczema and in the production of pyogenic skin infections.
Finally, one cannot dismiss the Congress without mentioning the clinical
demonstration of 170 cases of rare skin diseases. The individual dermatologist
is unlikely to deal with the majority of these more often than once in a lifetime.
Dermatologists spend so much of their time looking at the very common
conditions - eczema, warts and psoriasis - that they must be forgiven for
enthusing over the very rare.
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